Prevalence of atherosclerotic vascular disease among subjects with the metabolic syndrome with or without diabetes mellitus: the METS-GREECE Multicentre Study.
about
Epidemiology, classification, and modifiable risk factors of peripheral arterial diseaseDiagnosis and management of the metabolic syndrome in obesityFenofibrate: a novel formulation (Triglide) in the treatment of lipid disorders: a reviewDo we need a statin-nicotinic acid-aspirin mini-polypill to treat combined hyperlipidaemia?Self-reported prevalence of atherothrombosis in a general population sample of adults in Greece; a telephone survey.Waist circumference, not the metabolic syndrome, predicts glucose deterioration in type 2 diabetes.Metabolic syndrome in hypertensive patients: An unholy alliance.Combination drug treatment in obese diabetic patientsLDL cholesterol estimation in patients with the metabolic syndrome.Metabolic syndrome: definitions and controversies.Metabolic syndrome in the Mediterranean region: Current statusNon-low-density lipoprotein cholesterol-associated actions of ezetimibe: an overview.Clinical importance and therapeutic modulation of small dense low-density lipoprotein particles.The role of renin-angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal?The role of endocannabinoid system blockade in the treatment of the metabolic syndrome.Implementation of guidelines for the management of arterial hypertension. The impulsion studyEndothelial biology in the post-menopausal obese womanPerceived stress and vascular disease: where are we now?The impact of metabolic syndrome and hypertension on medical costs of patients with acute myocardial infarction at hospital.[Analysis of the criteria used for the definition of metabolic syndrome in patients with type 2 diabetes mellitus].Economic evaluation of irbesartan in combination with hydrochlorothiazide in the treatment of hypertension in Greece.Primary infrainguinal subintimal angioplasty in diabetic patients.Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease in a Mediterranean cohort.The control of dyslipidemia in outpatient clinics in Greece (OLYMPIC) Study.Excess body weight and risk of first-ever acute ischaemic non-embolic stroke in elderly subjects.Obstructive sleep apnea and cardiovascular risk: is metabolic syndrome the link?Cardiovascular risk assessment of South Asians in a religious setting: a feasibility study.Increased plasma levels of visfatin/pre-B cell colony-enhancing factor in obese and overweight patients with metabolic syndrome.
P2860
Q24681271-A7CFAEC0-D3E7-41AF-AB76-F51421C2367DQ28192856-7C5B91F8-08A4-4236-A345-3262152CD87AQ28220294-357804F3-1C5D-4517-83B1-8635CAAE8DE9Q28222549-2DFECE72-F91C-4168-B6F2-E084C82ED191Q33872893-83EB27EE-87CC-4777-B13C-FBC6AC4B4BF8Q34040213-03E4C66B-18D3-4F66-9570-D9EF7AEFA73BQ34251860-CEBD6CC3-3B3B-4F2A-AC19-E52DED636FB5Q34877652-EA11CB3F-4DEB-4D72-9FCF-1124B8FE1E2AQ34997089-23CB576E-1D86-4332-A960-E1E0C8C8798CQ35047747-F5BC549D-FF4C-4AE3-9F47-B2D8A9957F69Q35686365-92073C6F-2CF9-411A-8B14-72E03193DD3EQ36653658-871E2B07-96DB-4F5C-BCEE-F4A776048193Q36675450-9D31D6F7-D324-48A1-8DB2-50E5D4D1B465Q36709546-80D90BCB-4600-4B8A-BF05-D7869183576BQ36773310-4A1F3CF1-5CB6-41A6-8191-6B973260D8EDQ37239716-0A8E6FFA-3D23-4A90-BC89-5D277C32FFA6Q37600721-15484512-F88B-4082-97C8-0757A6925E4AQ38042592-D3F3F545-5C47-4A7C-91DF-07B91749317AQ40794271-072F2B86-12A0-4AFA-96E5-3DD546C732B9Q44198279-ED667302-C5D0-4EB3-9DEA-DB017F547729Q44573481-258F6342-D6B8-421D-937F-2DE20418DDABQ46569860-129BD877-770E-4E47-8C3F-CC1A72B1AE7DQ46793872-F10F5F8D-CE3F-45CC-8FEB-2E6DF779C2DCQ46835623-CCFF3213-4FC5-46DA-B01D-C0325273D318Q47282076-7CD111BD-4800-45F9-8F24-7C9BA562ACEDQ48259221-E87E4ED4-ACB4-4EBF-BB7B-FD7008494DE7Q48524602-5FB7E5AF-AB63-4B88-8CDC-A88D0CBF23E3Q51469849-AC9E45E6-4780-4403-9639-DA076D50B15D
P2860
Prevalence of atherosclerotic vascular disease among subjects with the metabolic syndrome with or without diabetes mellitus: the METS-GREECE Multicentre Study.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Prevalence of atherosclerotic ...... METS-GREECE Multicentre Study.
@en
Prevalence of atherosclerotic ...... METS-GREECE Multicentre Study.
@nl
type
label
Prevalence of atherosclerotic ...... METS-GREECE Multicentre Study.
@en
Prevalence of atherosclerotic ...... METS-GREECE Multicentre Study.
@nl
prefLabel
Prevalence of atherosclerotic ...... METS-GREECE Multicentre Study.
@en
Prevalence of atherosclerotic ...... METS-GREECE Multicentre Study.
@nl
P2093
P50
P921
P356
P1476
Prevalence of atherosclerotic ...... METS-GREECE Multicentre Study
@en
P2093
Anna I Kakafika
Athanasios A Papageorgiou
Athanasios N Symeonidis
Dimitri P Mikhailidis
METS-GREECE Collaborative Group
Stella S Daskalopoulou
Triandafillos P Didangelos
P304
P356
10.1185/030079904X5599
P407
P577
2004-11-01T00:00:00Z